from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0177/-

LFCtreatmentdescriptionclass of inhibitor

-0.555

Amikacinug/mL Amikacintranslation

-0.670

Cap5-10ug/mL Capreomycintranslation

-0.782

Rox10-50 ug/mL Roxithromycintranslation

0.082

SM2-5 ug/mL Streptomycintranslation

-0.506

Tet5-10 ug/mL Tetracyclinetranslation

-0.163

Rif0.2-5ug/mL Rifampicintranscription

0.924

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.770

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.980

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.193

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.117

Clofazimine10-13 ug/mL Clofaziminerespiration

0.596

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.001

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.300

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.757

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.323

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.026

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.757

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.489

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.774

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.277

KCN5-20 ug/mL Potassium cyaniderespiration

-0.217

NaN30.2-2 mM Sodium aziderespiration

0.542

Nigericin50 uM Nigericinrespiration

-0.850

TRC10-150 ug/mL Triclosanrespiration

-1.897

TRZ10-25 ug/mL Thioridazinerespiration

-2.288

Valinomycin0.5-10 uM Valinomycinrespiration

0.694

ZnSO42 mM ZnSO4respiration

-1.132

menadione6-10 ug/mL Menadionerespiration

-0.067

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.891

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.392

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.018

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.026

NRP_1Non-replicating persistence stage 1dosRassociated

1.077

Amp0.2mg/mL AmpicillincellWall

0.428

Cephalexin20-100 ug/mL CephalexincellWall

0.426

Cerulenin0.32-5 ug/mL CerulenincellWall

1.215

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.334

EMB10-20 ug/mL EthambutolcellWall

-0.054

Eta12-40 ug/mL EthionamidecellWall

0.220

INH0.2-0.4 ug/mL IsoniazidcellWall

0.373

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.607

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.884

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.274

BZA0.12 mg/mL BenzamidearomaticAmides

0.365

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.228

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.325

H2O24 mM hydrogen peroxideDNAdamaging

-0.125

Levo10 ug/mL LevofloxacinDNAdamaging

0.971

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.422

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.089

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.951

UVUV-irradiationDNAdamaging

-1.427

ARP41-4 ug/mL Antitubercular compound ARP4?

0.500

Antimycin12.5-50 ug/mL Antimycin A?

0.683

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.209

PA_110-50 ug/mL Antitubercular compound PA-1?

0.570

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.293

PA8240.2-2 ug/mL PA-824?

-0.840

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.290

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.647

Verapamil50 uM Verapamil?

0.422

mercaptoethanol2 mM 2-Mercaptoethanol?

0.879

methoxatin10-20 ug/mL Methoxatin?